Related references
Note: Only part of the references are listed.Imatinib Treatment for Idiopathic Pulmonary Fibrosis Randomized Placebo-controlled Trial Results
Craig E. Daniels et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)
Expression Analysis of Angiogenic Growth Factors and Biological Axis CXCL12/CXCR4 Axis in Idiopathic Pulmonary Fibrosis
Katerina M. Antoniou et al.
CONNECTIVE TISSUE RESEARCH (2010)
Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology
C. Vancheri et al.
EUROPEAN RESPIRATORY JOURNAL (2010)
Short Telomeres and Treatment of Pulmonary Fibrosis: Implications for Early Intervention
Katerina M. Antoniou et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Down-regulation of K-ras and H-ras in human brain gliomas
Rena Lymbouridou et al.
EUROPEAN JOURNAL OF CANCER (2009)
Identifying genotype-dependent efficacy of single and combined PI3K-and MAPK-pathway inhibition in cancer
Martin L. Sos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Idiopathic pulmonary fibrosis - Outcome in relation to smoking status
Katerina M. Antoniou et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Thy-1 Promoter Hypermethylation A Novel Epigenetic Pathogenic Mechanism in Pulmonary Fibrosis
Yan Y. Sanders et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
Survival of cancer cells is maintained by EGFR independent of its kinase activity
Zhang Weihua et al.
CANCER CELL (2008)
Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers
Jeffrey A. Engelman et al.
NATURE MEDICINE (2008)
Lung cancer in never smokers - a different disease
Sophie Sun et al.
NATURE REVIEWS CANCER (2007)
Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: Implications for treatment of fibrotic diseases
Ragini Vittal et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease
Borna Mehrad et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
A translational view of the molecular pathogenesis of lung cancer
Mitsuo Sato et al.
JOURNAL OF THORACIC ONCOLOGY (2007)
Phosphorylated Akt overexpression and loss of PTEN expression in non-small cell lung cancer confers poor prognosis
JM Tang et al.
LUNG CANCER (2006)
Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3′-Kinase/Akt pathway in vitro and in vivo
KA West et al.
CANCER RESEARCH (2004)
Activation of the pro-survival phosphatidylinositol 3-kinase/AKT pathway by transforming growth factor-β1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor
JC Horowitz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The epidemiology of interstitial lung disease and its association with lung cancer
G Raghu et al.
BRITISH JOURNAL OF CANCER (2004)
Expression and alteration of ras and p53 proteins in patients with lung carcinoma accompanied by idiopathic pulmonary fibrosis
T Takahashi et al.
CANCER (2002)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
MYCL1, FHIT, SPARC, p16INK4 and TP53 genes associated to lung cancer in idiopathic pulmonary fibrosis
K Demopoulos et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2002)
Histopathologic variability in usual and nonspecific interstitial pneumonias
KR Flaherty et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
The prognostic significance of the histologic pattern of interstitial pneumonia in patients presenting with the clinical entity of cryptogenic fibrosing alveolitis
AC Nicholson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Lung cancer and cryptogenic fibrosing alveolitis - A population-based cohort study
R Hubbard et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)
Share Paper
